The Ameliorating Effect of Myrrh on Scopolamine-Induced Memory Impairments in Mice

Abstract EN

Myrrh has been used since ancient times for the treatment of various diseases such as inflammatory diseases, gynecological diseases, and hemiplegia.

In the present study, we investigated the effects of aqueous extracts of myrrh resin (AEM) on scopolamine-induced memory impairments in mice.

AEM was estimated with (2E,5E)-6-hydroxy-2,6-dimethylhepta-2,4-dienal as a representative constituent by HPLC.

The oral administration of AEM for 7 days significantly reversed scopolamine-induced reduction of spontaneous alternation in the Y -maze test.

In the passive avoidance task, AEM also restored the decreased latency time of the retention trial by scopolamine treatment.

In addition, Western blot analysis and Immunohistochemistry revealed that AEM reversed scopolamine-decreased phosphorylation of Akt and extracellular signal-regulated kinase (ERK).

Our study demonstrates for the first time that AEM ameliorates the scopolamine-induced memory impairments in mice and increases the phosphorylation of Akt and ERK in the hippocampus of mice brain.

These results suggest that AEM has the therapeutic potential in memory impairments.